Related Experiment Video
Updated: Oct 24, 2025
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Acute mesenteric arterial thrombosis in severe SARS-Co-2 patient: A case report and literature review
Montserrat Del Carmen Valencia Romero1, Adrián Morales Cárdenas2, Alberto Briseño Fuentes3
1Resident of General Surgery, Hospital Civil Dr. Juan I. Menchaca, Mexico.
Introduction:
CoV-2 infection generates a pro-inflammatory state, which conditions the formation of thrombi that can affect any system. Multi-organ dysfunction is a cause of death, mesenteric ischemia in COVID 2019 patients reported is 1.9-4%.
Description Of The Case:
We present the case of a 73-year-old male patient who started with severe SARS-CoV-2 and arterial-type intestinal ischemia, necrosis of 3 m of the small intestine, based on SCARE 2020 guide.
Discussion:
Complications secondary to thrombosis are as follows; myocardial infarction 1.1%, ischemic cerebral events, 2.5-3.7%, microvascular thrombosis including mesenteric ischemia in less than 1% of cases. In patients with mesenteric ischemia the reported postoperative mortality is 23.8% of patients especially during the first 30 days.
Conclusion:
Intestinal thrombosis in patients with SARS-CoV-2 increases mortality.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause intestinal thrombosis, leading to increased mortality. This complication, though rare, significantly elevates the risk of death in affected patients.
Area of Science:
- Internal Medicine
- Gastroenterology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) infection induces a pro-inflammatory state, promoting thrombosis across various organ systems.
- Multi-organ dysfunction is a significant cause of mortality in COVID-19.
- Mesenteric ischemia is a reported complication in 1.9-4% of COVID-19 patients.
Observation:
- A case report details a 73-year-old male with severe SARS-CoV-2 infection and arterial-type intestinal ischemia.
- The patient experienced necrosis of 3 meters of small intestine, managed according to the SCARE 2020 guidelines.
Findings:
- Thrombotic complications of SARS-CoV-2 include myocardial infarction (1.1%), ischemic cerebral events (2.5-3.7%), and microvascular thrombosis.
- Mesenteric ischemia, a form of microvascular thrombosis, occurs in less than 1% of cases.
- Postoperative mortality for mesenteric ischemia patients is high at 23.8%, particularly within the first 30 days.
Implications:
- Intestinal thrombosis in COVID-19 patients is associated with increased mortality.
- Early recognition and management of mesenteric ischemia in SARS-CoV-2 patients are crucial for improving outcomes.
- Further research is needed to understand the mechanisms and optimize treatment strategies for COVID-19-associated thrombosis.
